MARKERS OF GUT DYSFUNCTION DO NOT EXPLAIN VARIABILITY IN RIFAMPIN PHARMACOKINETICS IN HIV-ASSOCIATED TUBERCULOSIS.

被引：0
|
作者：
Vinnard, C. [1 ]
Ravimohan, S. [2 ]
Tamuhla, N. [3 ]
Ivaturi, V. [4 ]
Pasipanodya, J. [5 ]
Srivastava, S. [5 ]
Modongo, C. [3 ]
Zetola, N. [3 ]
Weissman, D. [2 ]
Gumbo, T. [5 ]
Bisson, G. P. [2 ]
机构：
[1] Rutgers State Univ, Newark, NJ USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] UPenn Botswana Partnership, Gaborone, Botswana
[4] Univ Maryland, Baltimore, MD 21201 USA
[5] Baylor Univ, Dallas, TX USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-125
引用
收藏
页码：S51 / S52
页数：2
相关论文
共 8 条
  • [1] Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
    Vinnard, Christopher
    Ravimohan, Shruthi
    Tamuhla, Neo
    Pasipanodya, Jotam
    Srivastava, Shashikant
    Modongo, Chawangwa
    Zetola, Nicola M.
    Weissman, Drew
    Gumbo, Tawanda
    Bisson, Gregory P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 2020 - 2027
  • [2] Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?
    Lawn, S. D.
    Harries, A. D.
    Williams, B. G.
    Chaisson, R. E.
    Losina, E.
    De Cock, K. M.
    Wood, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (05) : 571 - 581
  • [3] Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
    D'Abramo, Alessandra
    Zingaropoli, Maria Antonella
    Oliva, Alessandra
    D'Agostino, Claudia
    Al Moghazi, Samir
    De Luca, Giulia
    Iannetta, Marco
    Mastroianni, Claudio Maria
    Vullo, Vincenzo
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [4] DIRECT INVOLVEMENT OF HIV IN HIV-ASSOCIATED NEPHROPATHY - CORRELATION OF HIV VIRAL BURDEN WITH ULTRASTRUCTURAL MARKERS, HISTOPATHOLOGICAL CHANGES AND RENAL DYSFUNCTION
    CHOI, Y
    MONIEM, H
    HU, Y
    MARKOVICH, B
    COHEN, B
    LABORATORY INVESTIGATION, 1992, 66 (01) : A101 - A101
  • [5] Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated Tuberculosis
    van Halsema, Clare L.
    Fielding, Katherine L.
    Chihota, Violet N.
    George, Elizabeth C.
    Lewis, James J.
    Churchyard, Gavin J.
    Grant, Alison D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (01) : 104 - 108
  • [6] Changes in the balance of Th17/Treg cells and oxidative stress markers in patients with HIV-associated pulmonary tuberculosis who develop IRIS
    Wen, Long
    Shi, Lei
    Wan, Shan-Shan
    Xu, Tao
    Zhang, Lei
    Zhou, Zhi-Guo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (06)
  • [7] Brief Report: Detection of Urine Lipoarabinomannan Is Associated With Proinflammatory Innate Immune Activation, Impaired Host Defense, and Organ Dysfunction in Adults With Severe HIV-Associated Tuberculosis in Uganda
    Cummings, Matthew J.
    Bakamutumaho, Barnabas
    Jain, Komal
    Price, Adam
    Owor, Nicholas
    Kayiwa, John
    Namulondo, Joyce
    Byaruhanga, Timothy
    Muwanga, Moses
    Nsereko, Christopher
    Nayiga, Irene
    Kyebambe, Stephen
    Che, Xiaoyu
    Sameroff, Stephen
    Tokarz, Rafal
    Wong, Wai
    Postler, Thomas S.
    Larsen, Michelle H.
    Lipkin, W. Ian
    Lutwama, Julius J.
    O'Donnell, Max R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 93 (01) : 79 - 85
  • [8] INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial
    Naidoo, Anushka
    Dooley, Kelly E.
    Naidoo, Kogieleum
    Padayatchi, Nesri
    Yende-Zuma, Nonhlanhla
    Perumal, Rubeshan
    Dorse, Gillian
    Boodhram, Resha
    Osuala, Emmanuella Chinonso
    BMJ OPEN, 2022, 12 (11):
1